Hosted on MSN4mon
EU Commission fines Teva $500 million for trying to stop rival's multiple sclerosis drug
The EU Commission said Teva's actions may have prevented significant savings by countries across Europe, with other versions of the drug possibly 80% cheaper than Copaxone. Teva will have to pay a ...
European Commission fines MS drug maker Teva over improper patent use
The European Commission said the pharmaceutical firm "misused the patent system to artificially extend patent protection" for ...